AMERICAN CARDIOVASCULAR RESEARCH F… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1986

Legal Domicile

Principal Officer

MICHAEL LOBEL

Phone

2128685781

Tax Period

2023-10-01 to 2024-09-26

AMERICAN CARDIOVASCULAR RESEARCH FOUNDATION INC, founded in 1986, is a micro nonprofit that reported $8K in total revenue in fiscal year 2023. Revenue fell 77% from the prior year — a significant decline worth monitoring. Expenses of $143K exceeded revenue, resulting in a 1803% operating deficit.

Mission

SUPPORT CLINICAL AND EXPERIMENTAL SCIENTIFIC INVESTIGATIONS OF THE CAUSES OF AND TREATMENTS FOR HEART DISEASES.

Program Service Accomplishments

Program 1

Expenses: $120,948

STATISTICAL RESEARCH RELATED TO THE CAUSES OF AND TREATMENTS FOR HEART DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $275

Program Service Revenue $0

Investment Income $7,255

Other Revenue $0

TOTAL REVENUE $7,530

Expense Breakdown

Grants Paid $106,421

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $120,948

Other Expenses $36,852

TOTAL EXPENSES $143,273

Year-over-Year Comparison

	2023	2022	Change
Revenue	$7,530	$32,531	-0.8%
Expenses	$143,273	$88,901	+0.6%
Net Income	$-135,743	$-56,370	+1.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SARA BROOK	PRESIDENT	0.50	Officer Director	$0	$0	$0
MICHAEL LOBEL	SEC/TREAS	0.50	Officer Director	$0	$0	$0
JEANNIE SCHIAVONE	VICE PRESIDENT	0.50	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$7,530	$143,273	No data	$-135,743
2023	$32,531	$88,901	$135,743	$-56,370
2022	$31,221	$148,712	$192,113	$-117,491
2021	$80,608	$80,893	$309,604	$-285
2020	$71,110	$145,011	$309,889	$-73,901
2019	$32,173	$213,167	$383,790	$-180,994

AMERICAN CARDIOVASCULAR RESEARCH FOUNDATION INC